NCT05384626 2026-05-27A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)Nuvalent Inc.Phase 1/2 Recruiting840 enrolled